TrialNature communications2026

Cadonilimab plus lenvatinib in advanced endometrial cancer: the multicenter single-arm phase II CLEAR-EC trial.

Lin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.